Rebecca Stephens last checked in with University of California San Francisco researchers running her cancer trial by video, and the coronavirus could make that routine.
The Covid-19 pandemic is forcing cancer trials to get creative, accelerating changes patient advocates have long sought to make it easier for more people to join the studies.
For patients like Stephens, who’s battling colon and liver cancer, that means she got her lab work and vital signs done by local providers in Santa Rosa, Calif., rather than making the two hour trip to San Francisco, which would require her husband or father to drive ...